Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Recenti Progressi in Medicina|January 22, 2025
[Patient with diffuse large B-cell lymphoma: a good example of network in care]Maria Chiara Tisi
Recenti Progressi in Medicina|February 20, 2026
[CAR-T: an effective option in primary refractory patients.]Maria Chiara Tisi, Michele Wieczorek, Marcello Riva
Annals of Nuclear Medicine|February 22, 2018
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET)Salvatore Annunziata, Annarosa Cuccaro, Maria Chiara Tisi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Use of a maturity model for facilitating the introduction of CAR T-cell therapy-Results of the START CAR-T projectStefania Bramanti, Matteo G Carrabba, Alice Di Rocco, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 7, 2015
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complicationMaria Chiara Tisi, Giuseppe Ausoni, Maria Gabriella Vita, et al.
Hematological Oncology|October 8, 2025
Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian PerspectiveGiacomo Loseto, Maria Chiara Tisi, Antonella Anastasia, et al.
Cytotherapy|July 8, 2020
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasksPierangela Palmerini, Anna Dalla Pietà, Roberta Sommaggio, et al.
Cancer Medicine|December 23, 2017
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapyStefan Hohaus, Maria Chiara Tisi, Silvia Bellesi, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2014
Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarkerManuela Giachelia, Valentina Bozzoli, Francesco D'Alò, et al.
Pageof 6